Synapse - Works

Results (39)

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

Journal Article

Praiss, A. M.; Zhou, Q.; Iasonos, A.; Moukarzel, L.; Dessources, K.; Soldan, K.; Su, K.; Sonoda, Y.; Roche, K. L.; Gardner, G. J.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Journal Article

Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study

Journal Article

Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Effect of a predictive model on planned surgical duration accuracy, patient wait time, and use of presurgical resources: A randomized clinical trial

Journal Article

Strömblad, C. T.; Baxter-King, R. G.; Meisami, A.; Yee, S. J.; Levine, M. R.; Ostrovsky, A.; Stein, D.; Iasonos, A.; Weiser, M. R.; Garcia-Aguilar, J.; more...
JAMA Surgery (2021)

Fulltext@MSK | Save

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Journal Article

Rubinstein, M. M.; Grisham, R. N.; Cadoo, K.; Kyi, C.; Tew, W. P.; Friedman, C. F.; O'Cearbhaill, R. E.; Zamarin, D.; Zhou, Q.; Iasonos, A.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)

Meeting Abstract

Grisham, R. N.; Li, K.; Iasonos, A.; Girshman, J.; Cadoo, K. A.; Kyi, C.; Makker, V.; Cohen, S. M.; O'Cearbhaill, R. E.; Sabbatini, P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

A pilot study of nivolumab in combination with front-line neoadjuvant dose-dense paclitaxel and carboplatin chemotherapy in patients with high-grade serous ovarian cancer

Meeting Abstract

Friedman, C. F.; Snyder, A.; Abu-Rustum, N. R.; Broach, V.; Brown, C. L.; Bykov, Y.; Cadoo, K. A.; Chi, D. S.; Cohen, S.; Eid, K. T.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

A randomized phase II trial of secondary cytoreductive surgery (SCS) plus /- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC)

Meeting Abstract

Zivanovic, O.; Chi, D.; Zhou, Q.; Iasonos, A.; Makker, V.; Grisham, R. N.; Konner, J. A.; Diaz, J. P.; Brown, A. K.; Langstraat, C. L.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

Journal Article

Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
Cancer (2020)

Fulltext@MSK | Save

A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma

Meeting Abstract

Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save